← Eichor
Study identifier: NCT04486638 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Dengvaxia US Pregnancy Registry

Condition: Dengue Virus Infection  ·  Sponsor: Sanofi Pasteur, a Sanofi Company

PhaseN/A
Planned participants500
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

The primary objective of this study is to assess maternal, obstetrical, pregnancy, and neonatal and infant outcomes among women and their offspring(s) vaccinated with Dengvaxia during their pregnancy

This description comes directly from the study's public registry record.

Talk to the study team

Dengvaxia US Pregnancy Registry HelpLine  ·  1-800-822-2463

Trial Transparency email recommended (Toll free number for US & Canada)  ·  800-633-1610  ·  contact-us@sanofi.com

Always discuss trial participation with your own doctor first.

Locations (1)

Investigational SiteSan Juan, Puerto RicoRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04486638